Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Oct 9, 2026 is 3.71 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 2.59 % — a change of 43.56% (higher).

EBIT/Assets

3.71 %

YoY

43.56%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Vcanbio Cell & Gene Engineering Corp is 2025 3.71 % . Operating Income to Assets Ratio (EBIT/Assets) of Vcanbio Cell & Gene Engineering Corp was 2024 2.59 % . It decreases by 43.56% higher compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
0.99 CNY
Jan 1, 2019
2.35 CNY
Jan 1, 2020
-1.90 CNY
Jan 1, 2021
4.37 CNY
Jan 1, 2022
2.95 CNY
Jan 1, 2023
2.42 CNY
Jan 1, 2024
2.59 CNY
Jan 1, 2025
3.71 CNY
The Vcanbio Cell & Gene Engineering Corp EBIT/Assets history
YEAREBIT/AssetsYoY
3.71 %+43.56%
2.59 %+6.76%
2.42 %-17.92%
2.95 %-32.40%
4.37 %-329.89%
-1.90 %-180.87%
2.35 %+136.35%
0.99 %-52.46%
2.09 %-25.29%
2.80 %-68.78%
8.96 %+281.06%
2.35 %—
Access this data via the Eulerpool API
Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

Operating Income to Assets Ratio (EBIT/Assets) of Vcanbio Cell & Gene Engineering Corp is 3.71 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Vcanbio Cell & Gene Engineering Corp changed from 2.59 % to 3.71 %, representing a 43.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Vcanbio Cell & Gene Engineering Corp with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Vcanbio Cell & Gene Engineering Corp

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Vcanbio Cell & Gene Engineering Corp